James Peyer, Ph.D. was only sixteen when he decided he would dedicate his life to preventing the diseases of aging. In 2016 he founded Apollo Ventures (www.apollo.vc), an early-stage venture capital firm and incubator with a focus on biotech companies that are creating the next generation of medicines: therapeutics to prevent age-related disease and extend healthy lifespan. Before Apollo he was a consultant with McKinsey & Company's biotech and pharma practice, where he specialized in biotech entrepreneurship, drug launches for regenerative medicines, and R&D pipeline analysis. He founded his first company, Genotyp, at age 21 to overhaul hands-on science education in the US. The first biotech company to receive funding through Kickstarter, Genotyp's biotech equipment leasing model and instructor training earned it the approval of the White House and the NIH. James received a BA in biology with special honors from the University of Chicago, where he was a National Merit Scholar. He received his Ph.D. from the University of Texas Southwestern Medical Center in Dallas, where he was a National Science Foundation Fellow with a focus on the basic biology of stem cells and improving gene therapies.
The author declares no conflict of financial interest with the article written above.